Michelle Griffin
Director/Board Member chez ADAPTIVE BIOTECHNOLOGIES CORPORATION
Fortune : 18 785 $ au 31/03/2024
Profil
Michelle R.
Griffin is an Independent Director at HTG Molecular Diagnostics, Inc. and Adaptive Biotechnologies Corp.
She was formerly Chairman at Universal Cells, Inc., Director at Sonus Pharmaceuticals, Inc., Virginia Mason Medical Center, Opexa Therapeutics, Inc., PhaseRx, Inc., and Polynoma LLC.
She was also Chief Financial Officer at Corixa Corp.
and Chief Financial Officer & Senior Vice President at Dendreon Corp.
& Emergent Product Development Seattle.
She was Chief Operating Officer & Senior Vice President at Emergent Product Development Seattle and Chief Financial Officer & Executive Vice President at OncoGenex Pharmaceuticals, Inc. She is currently an Independent Director at Acer Therapeutics, Inc. and Chinook Therapeutics, Inc. She was also a Principal at Pacific Biotechnology Consulting Group.
She received her undergraduate degree from George Mason University and her MBA from Seattle University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 01/04/2023 | 5 852 ( 0,00% ) | 18 785 $ | 31/03/2024 | |
| 01/03/2023 | 13 ( 0,00% ) | 0 $ | 31/03/2024 |
Postes actifs de Michelle Griffin
| Sociétés | Poste | Début |
|---|---|---|
| HTG MOLECULAR DIAGNOSTICS, INC. | Director/Board Member | 16/08/2018 |
| ADAPTIVE BIOTECHNOLOGIES CORPORATION | Director/Board Member | 01/03/2019 |
Anciens postes connus de Michelle Griffin
| Sociétés | Poste | Fin |
|---|---|---|
| ACER THERAPEUTICS INC. | Director/Board Member | 17/11/2023 |
| CHINOOK THERAPEUTICS, INC. | Director/Board Member | 11/08/2023 |
Pacific Biotechnology Consulting Group
 Pacific Biotechnology Consulting Group Miscellaneous Commercial ServicesCommercial Services Pacific Biotechnology Consulting Group provides consulting services to biotechnology companies. The private company is based in Seattle. | Corporate Officer/Principal | 01/01/2020 |
Virginia Mason Medical Center
 Virginia Mason Medical Center Medical/Nursing ServicesHealth Services Virginia Mason Medical Center provides healthcare services. It offers primary and cancer care, diabetes center, digestive disorders, heart care, neurology and neurosurgery, medicine, surgery, urology, and orthopedics and sports. The company was founded by James Tate Mason, John M. Blackford, and Maurice Dwyer in 1920 and is headquartered in Seattle, WA. | Director/Board Member | 01/01/2018 |
Virginia Mason Health System
 Virginia Mason Health System Hospital/Nursing ManagementHealth Services Virginia Mason Health System offers medical services. It is the parent company of a group of affiliated organizations including Virginia Mason Medical Center and the Benaroya Research Institute at Virginia Mason. The firm support the healthcare and research missions of the Virginia Mason Medical Center and Benaroya Research Institute at Virginia Mason. The company was founded in 1920 and is headquartered in Seattle, WA. | Director/Board Member | 01/01/2018 |
Formation de Michelle Griffin
| George Mason University | Undergraduate Degree |
| Seattle University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| HTG MOLECULAR DIAGNOSTICS, INC. | Commercial Services |
| PHASERX, INC. | Health Technology |
| ADAPTIVE BIOTECHNOLOGIES CORPORATION | Health Technology |
| Entreprise privées | 13 |
|---|---|
Sonus Pharmaceuticals, Inc.
 Sonus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sonus Pharmaceuticals, Inc. engaged in the development of drugs for the treatment of cancer and related therapies. Its primary product TOCOSOL Paclitaxel, was an injectable paclitaxel emulsion for nonsmall cell lung cancer, ovarian cancer and bladder cancer. Sonus Pharmaceuticals was incorporated in 1991 and was headquartered in Bothell, WA. | Health Technology |
Corixa Corp.
 Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Health Technology |
Dendreon Corp.
 Dendreon Corp. Medical SpecialtiesHealth Technology Dendreon Corp. discovers, develops and commercializes novel products for the treatment of cancer. The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a variety of tumor types. It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. Dendreon was founded by Christopher S. Henney, Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA. | Health Technology |
Emergent Product Development Seattle
 Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Emergent Product Development Seattle discovers and develops biopharmaceutical products. It focuses on the discovery and development of novel medicines to treat inflammatory diseases and cancer. The company was founded by Peter A. Thompson, Jeffrey A. Ledbetter and Kendall M. Mohler in March 1999 and is headquartered in Seattle, WA. | Health Technology |
Universal Cells, Inc.
 Universal Cells, Inc. BiotechnologyHealth Technology Universal Cells, Inc. develops, licenses and commercializes stem cell therapies. The company was founded by Claudia Mitchell and David Russell and is headquartered in Seattle, WA. | Health Technology |
Virginia Mason Medical Center
Virginia Mason Medical Center Medical/Nursing ServicesHealth Services Virginia Mason Medical Center provides healthcare services. It offers primary and cancer care, diabetes center, digestive disorders, heart care, neurology and neurosurgery, medicine, surgery, urology, and orthopedics and sports. The company was founded by James Tate Mason, John M. Blackford, and Maurice Dwyer in 1920 and is headquartered in Seattle, WA. | Health Services |
Opexa Therapeutics, Inc.
 Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | Health Technology |
OncoGenex Pharmaceuticals, Inc.
 OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoGenex Pharmaceuticals, Inc. is a biopharmaceutical company, which engages develops and commercializes new cancer therapies that address treatment resistance in cancer patients. Its product include custirsen, apatorsen, and OGX-225. The company was founded by Martin E. Gleave and Scott Daniel Cormack in October 1991 and is headquartered in Bothell, WA. | Health Technology |
Polynoma LLC
 Polynoma LLC BiotechnologyHealth Technology Part of CK Life Sciences International (Holdings), Inc., Polynoma LLC is an immuno-oncology focused biopharmaceutical company headquartered in San Diego, CA. Polynoma's lead asset is a novel polyvalent antigen vaccine, Seviprotimut-L, for the prevention of recurrence of melanoma. The vaccine has been safely administered in more than 1,000 patients. Polynoma is an immuno-oncology company developing a novel polyvalent antigen therapy for the treatment of melanoma. The private company was founded by Paul A. Hopper. | Health Technology |
Virginia Mason Health System
Virginia Mason Health System Hospital/Nursing ManagementHealth Services Virginia Mason Health System offers medical services. It is the parent company of a group of affiliated organizations including Virginia Mason Medical Center and the Benaroya Research Institute at Virginia Mason. The firm support the healthcare and research missions of the Virginia Mason Medical Center and Benaroya Research Institute at Virginia Mason. The company was founded in 1920 and is headquartered in Seattle, WA. | Health Services |
Acer Therapeutics, Inc.
 Acer Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Acer Therapeutics, Inc. is a pharmaceutical company, which engages in the acquisition, development, and commercialization of therapies for medical needs. Its product pipeline includes Olpruva, Edsivo, and ACER-801. Olpruva is used for the treatment of urea cycle disorders. Edsivo is a type of celiprolol used in treating Vascular Ehlers-Danlos syndrome. ACER-001 treats menopausal related Vasomotor symptoms. The company was founded by Chris Schelling on March 15, 1991 and is headquartered in Newton, MA. | Health Technology |
Pacific Biotechnology Consulting Group
Pacific Biotechnology Consulting Group Miscellaneous Commercial ServicesCommercial Services Pacific Biotechnology Consulting Group provides consulting services to biotechnology companies. The private company is based in Seattle. | Commercial Services |
Chinook Therapeutics, Inc.
 Chinook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Chinook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing, and commercializing precision medicines for rare, severe chronic kidney diseases. The company was founded in 2019 and is headquartered in Seattle, WA. | Health Technology |
